Literature DB >> 11129268

Update in medical treatment of Crohn's disease.

M D Regueiro1.   

Abstract

Crohn's disease is an inflammatory bowel disorder that has no known cause. The goal of medical treatment is to control active disease, induce and maintain clinical remission, and treat complications. Anti-inflammatory medications and immunomodulatory therapies are the primary treatment modalities for Crohn's disease. The categories of standard treatment include the 5-aminosalicylic acid compounds, corticosteroids, antibiotics, and immunomodulators. New biologic therapy has been developed to better target the immune mediators that are active in Crohn's disease. Infliximab is the first of the biologic agents approved for the treatment of fistulizing and active Crohn's disease. Despite medical advances in treatment, there is still no cure for Crohn's disease.

Entities:  

Mesh:

Year:  2000        PMID: 11129268     DOI: 10.1097/00004836-200012000-00004

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  3 in total

Review 1.  Management of arthropathy in inflammatory bowel diseases.

Authors:  Rosario Peluso; Francesco Manguso; Maria Vitiello; Salvatore Iervolino; Matteo Nicola Dario Di Minno
Journal:  Ther Adv Chronic Dis       Date:  2015-03       Impact factor: 5.091

2.  Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease.

Authors:  Kyle Joshua Fortinsky; David Kevans; Judy Qiang; Wei Xu; Felipe Bellolio; Hillary Steinhart; Raquel Milgrom; Gordon Greenberg; Zane Cohen; Helen Macrae; Joanne Stempak; Robin McLeod; Mark S Silverberg
Journal:  Dig Dis Sci       Date:  2016-10-24       Impact factor: 3.199

Review 3.  Immunosuppressive therapies for inflammatory bowel disease.

Authors:  Talia Zenlea; Mark A Peppercorn
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.